Pretreatment Computed Tomography-Based Machine Learning Models to Predict Outcomes in Hepatocellular Carcinoma Patients who Received Combined Treatment of Trans-Arterial Chemoembolization and Tyrosine Kinase Inhibitor

Aim: Trans-arterial chemoembolization (TACE) in combination with tyrosine kinase inhibitor (TKI) has been evidenced to improve outcomes in a portion of patients with hepatocellular carcinoma (HCC). Developing biomarkers to identify patients who might benefit from the combined treatment is needed. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Qianqian, Zhu, Peng, Li, Changde, Yan, Meijun, Liu, Song, Zheng, Chuansheng, Xia, Xiangwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168370/
https://www.ncbi.nlm.nih.gov/pubmed/35677305
http://dx.doi.org/10.3389/fbioe.2022.872044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168370/
https://www.ncbi.nlm.nih.gov/pubmed/35677305
http://dx.doi.org/10.3389/fbioe.2022.872044

Ejemplares similares